New drugs for hepatitis and diabetes may come from Siberia

Print 26 April 2016
Marchmont Innovation News

In Siberia, scientists have leveraged years of research into the properties of stem cells in a new project aimed at developing new drugs to fight hepatitis and diabetes. 

The research is said to have led them to discover that stem cells are capable of migrating into the affected areas of the human body, thus causing tissue regeneration. Moreover, the scientists found that such activity is not dependent on what has caused an affliction. 

The researchers have developed a drug that is said to be able to stimulate an increase in stem cells concentration in peripheral blood. Solutions that work in a more or less similar way do already exist, but they are prohibitive for most patients. 

The Siberian scientists are reported to have found a method to develop drug candidates with an increased biological accessibility, which would not be rejected by the human body. One such candidate is expected to help treat C type hepatitis. 

Another one, called immobilized hyaluronidase, may have even brighter prospects in the market, the scientists think. Developed based on the same technology, the drug candidate is said to be able to boost the growth of cells considerably. The solution is expected to emerge as a powerful drug for lung problems and diabetes.

Source

Return